WARF is the private, nonprofit patent and licensing organization for the University of Wisconsin–Madison.
Business Model: Non-Profit
Revenue: $6M
Employees: 51-200
Address: 614 Walnut Street
City: Madison
State: WI
Zip: 53726
Country: US
WARF) is the private, nonprofit patent and licensing organization for the University of Wisconsin–Madison, one of the world’s great research universities. WARF was founded in 1925 and is a pioneer and innovator among university-based technology transfer offices. WARF’s mission is to support, aid and encourage UW–Madison research by protecting its discoveries and licensing them to commercial partners for beneficial use in the real world. It is best known for commercializing groundbreaking vitamin D therapies, the revolutionary anticoagulant Coumadin®, innovative medical imaging and cancer radiation systems, and its patents for human embryonic stem cells.
Contact Phone:
+16089609850
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2023 | Realta Fusion | Seed Round | 9M |
4/2014 | Isomark Health, Inc | Venture Round | 150k |
11/2015 | Holos | Grant | 60k |
1/2014 | Madison Vaccines | Series A | 8M |
10/2018 | SimpleMachines | Series A | 0 |
8/2021 | Pyran | Seed Round | 0 |
8/2021 | Isomark Health, Inc | Seed Round | - |
7/2021 | Asto CT | Series B | 25.3M |
3/2015 | Madison Vaccines | Series A | 3M |
3/2007 | Mithridion | Series A | 2.2M |
5/2017 | SimpleMachines | Seed Round | 2.9M |
2/2008 | NeuWave Medical | Series A | 4.5M |
9/2015 | StudyBlue | Venture Round | 3.9M |
6/2014 | StudyBlue | Venture Round | 1.7M |
1/2005 | OpGen | Series B | 0 |
5/2016 | FluGen | Venture Round | 0 |
10/2021 | Immuto Scientific | Seed Round | 0 |
3/2021 | Stuart Therapeutics | Series A | 0 |
4/2017 | FluGen | Series A | 0 |
8/2015 | FluGen | Series A | 0 |
4/2003 | Roche NimbleGen | Series D | 0 |
11/2013 | Silatronix | Venture Round | 0 |
4/2021 | OnLume | Series A | 7M |
10/2001 | Roche NimbleGen | Series B | 10.5M |
8/2020 | LÜM | Seed Round | 0 |
12/2007 | Deltanoid Pharmaceuticals | Series B | 12M |
7/2021 | Leo Cancer Care | Series B | 25.3M |
5/2016 | Isomark Health, Inc | Venture Round | 1k |
1/2016 | Isomark Health, Inc | Funding Round | 130k |
8/2018 | HealthMyne | Series B | 15M |
9/2016 | HealthMyne | Venture Round | 6.9M |
11/2008 | Cellular Dynamics International | Series A | 18M |
8/2012 | NeuWave Medical | Equity | 14M |
1/2020 | PROMISS Diagnostics | Seed Round | 400k |
4/2020 | Live Undiscovered Music (L√úM) | Seed Round | 3M |
10/2021 | Immuto Scientific | Seed Round | 0 |
8/2021 | Pyran | Seed Round | 0 |
8/2021 | Isomark Health, Inc | Seed Round | - |
7/2021 | Leo Cancer Care | Series B | 0 |
4/2021 | OnLume | Series A | 0 |
3/2021 | Stuart Therapeutics | Series A | 0 |
8/2020 | LÜM | Seed Round | 0 |
4/2020 | Live Undiscovered Music (L√úM) | Seed Round | 0 |
1/2020 | PROMISS Diagnostics | Seed Round | 0 |
10/2018 | SimpleMachines | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|